Effect of Liraglutide or Exenatide Added to an Ongoing Treatment on Blood Glucose Control in Subjects With Type 2 Diabetes
Clinical trial NCT00518882 · COMPLETED
Trial details
- NCT number
- NCT00518882
- Sponsor
- Novo Nordisk A/S
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2007-08-01
- Primary completion
- 2008-04-01
- Enrollment
- 467
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.